CORMEDIX INC WTS EXP 04/30/15
CRMD.WS
CRMD.WS was delisted on the 29th of April, 2015.
4 hedge funds and large institutions have $50K invested in CORMEDIX INC WTS EXP 04/30/15 in 2014 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
22% less capital invested
Capital invested by funds: $64K → $50K (-$14K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
-$30 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
AQR Capital Management
Greenwich,
Connecticut
| $39K | – | – | – |
|
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $10K | – | – | – |
|
|
U
3
UBS
Zurich,
Switzerland
| $1K | -$30 | -100 | -3% |
|
CRMD.WS Hedge Fund Activity: Q3 2014 in Review
4 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in CORMEDIX INC WTS EXP 04/30/15 (CRMD.WS) for Q3 2014, worth a combined $50K — down 22% from $64K a quarter earlier.
Fund positioning in CRMD.WS was balanced in Q3 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS, cutting an estimated $30.
- 4 institutional investors held CORMEDIX INC WTS EXP 04/30/15 (CRMD.WS) as of Q3 2014, unchanged from Q2 2014.
- Funds reported $50K of CORMEDIX INC WTS EXP 04/30/15 stock for Q3 2014, down 22% quarter-over-quarter.
- 0 funds opened new CORMEDIX INC WTS EXP 04/30/15 positions in Q3 2014 and 0 closed out.
- The largest CORMEDIX INC WTS EXP 04/30/15 seller in Q3 2014 was UBS, an estimated $30 sold.
Based on aggregated 13F filings for Q3 2014.